Linezolid clearance during continuous venovenous hemodiafiltration: a case report
| Autor: | Jessica J. Ellis, Bruce A. Mueller, Deborah A. Pasko, Charles A. Peloquin, Daryl D. DePestel, Michael D. Kraft |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Male
medicine.medical_treatment Critical Illness Anuria Drug Administration Schedule chemistry.chemical_compound Pharmacokinetics Anti-Infective Agents Hemofiltration Acetamides medicine Humans heterocyclic compounds Pharmacology (medical) Chromatography High Pressure Liquid Oxazolidinones Antibacterial agent Aged Aged 80 and over business.industry Critically ill organic chemicals Linezolid Half-life Continuous venovenous hemodiafiltration biochemical phenomena metabolism and nutrition bacterial infections and mycoses chemistry Anesthesia Area Under Curve bacteria medicine.symptom business Half-Life |
| Zdroj: | Pharmacotherapy. 23(8) |
| ISSN: | 0277-0008 |
| Popis: | Objective. To determine the linezolid clearance and serum concentrations in a critically ill man receiving continuous venovenous hemodiafiltration (CVVHDF). Methods. Intravenous linezolid 600 mg every 12 hours was administered to a critically ill, 85-year-old man with anuria who was receiving CVVHDF at a dialysate flow rate of 2000 ml/hour and a mean ultrafiltrate production rate of 775 ml/hour. Samples of blood and spent dialysate and ultrafiltrate were obtained at the time of linezolid peaks and troughs, and linezolid concentrations were determined. Results. The CVVHDF yielded a mean linezolid clearance of 36.5 ml/minute and an elimination half-life of 7.5 hours. The linezolid saturation coefficient ranged from 0.77‐0.81. Administration of intravenous linezolid 600 mg every 12 hours yielded suitable serum trough concentrations. Conclusion. Administration of intravenous linezolid 600 mg every 12 hours maintained therapeutic serum trough concentrations in this critically ill patient receiving CVVHDF. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text